Aditi Tripathi

Head of Scientific Writing & Publication Strategy – Ichelon

A specialist in scientific writing, evidence synthesis, and structured publication governance, Aditi  leads manuscript development strategy at Ichelon for pharma and healthcare organizations operating in regulated environments.
Her work focuses on transforming complex clinical and safety data into submission-ready, reviewer-ready, and audit-traceable scientific documentation.

With a Master of Pharmacy (Pharmaceutics) from IIT (BHU), Varanasi, she integrates strong scientific foundations with SOP-driven execution systems designed for high-accountability publishing.

About Aditi

Aditi specializes in structured manuscript development, evidence synthesis, and journal-compliant scientific documentation. Her work focuses on transforming complex clinical and safety data into:

With deep domain knowledge in pharmacovigilance, she specializes in translating complex safety data into structured, publication-ready manuscripts aligned with global regulatory and reporting standards.

Vision

Aditi is committed to strengthening scientific publishing standards in India by advancing:

She believes publication success is driven not only by scientific strength, but by disciplined execution systems

Strategic Role at Ichelon

As Head of Scientific Writing & Publication Strategy, Aditi oversees:

She leads and governs Ichelon’s Publication Readiness System™ (PRS) — a structured execution framework built to ensure quality, traceability, and inspection preparedness.

Core Expertise

Evidence Synthesis & Scientific Writing

Systematic literature reviews, meta-analysis structuring, PRISMA documentation, narrative development, and reproducible manuscript architecture.

Original Research Manuscripts (IMRaD)

Clinical rationale articulation, reproducible methods documentation, data-consistent results narration, structured discussion strategy, and journal-specific alignment.

Journal Strategy & Risk Reduction

Journal shortlisting, scope mapping, desk rejection risk matrix development, audience alignment, and submission cycle optimization.

Quality & Compliance Governance

Reporting guideline integration (CONSORT / PRISMA / STROBE), ethical disclosures, similarity mitigation workflows, technical formatting validation, and submission QC.

Domain Expertise

Pharmacovigilance-aligned safety narratives, ADR documentation systems, biosimilar safety publications, and regulatory-sensitive manuscript positioning.

Selected Scientific Publications

2026

Regulatory Harmonization in Indian Pharmacovigilance: Convergence with Global Standards (2026)

A structured evaluation of India’s drug safety regulatory alignment with international reporting systems.

2025

Evolution and Impact of India’s Pharmacovigilance Programme: A Decade of Progress (2025)

A structured evaluation of India’s drug safety regulatory alignment with international reporting systems.

2025

Pharmacovigilance of Biosimilars in India: Regulatory Framework & Future Directions (2025)

Assessment of lifecycle safety governance for biosimilars in India.

2025

Patient-Centric Pharmacovigilance: Innovative Approaches to ADR Reporting (2025)

Exploration of participatory safety reporting and digital capture models.

Therapeutic & Domain Experience

Pharmacovigilance & Drug Safety Documentation

Biosimilars & Biologics Publications

Post-Marketing Surveillance Narratives

Hospital-Based ADR Reporting Systems

Digital Health & AI in Drug Safety

Education & Professional Training

Master of Pharmacy (Pharmaceutics)

IIT (BHU), Varanasi

Specialized Training in:

Focus Areas

Structured Journal-Fit Strategy to Reduce Desk Rejections

Embedding CONSORT/PRISMA Early in Manuscript Development

AI Integration in Scientific Writing Workflows

CDSCO Safety Updates: Publication Implications

Consult with the Expert

Interested in strengthening your manuscript quality, journal alignment strategy, or publication governance system?